Muhammad Amer Awan, MD, FRCSEd, FRCOphth, FRCS Glasgow, FACS, FASRS

Muhammad Amer Awan, MD, FRCSEd, FRCOphth, FRCS Glasgow, FACS, FASRS

Shifa International Hospital
Consultant Ophthalmologist & Retinal Specialist
H-8/4
Pitras Bukhari Road
Islamabad , 44000
Pakistan map
+93 251-846-4646 office

00923125702467 office

https://www.amerawan.com


Professional Affiliations

Academic Appointments
  • Professor of Ophthalmology, Shifa Tameer-e-Millat University, Islamabad, Pakistan
Hospital Appointments
  • 1) Consultant Retina Specialist, Shifa International Hospital, Islamabad, Pakistan 2013
  • 2) Chief of Ophthalmology, Shifa International Hospital, Islamabad, Pakistan 2024.
  • 3) Consultant Vitreo-retinal Surgeon, University Hospital Ayr, UK, 2011

Education and Training

Retinal fellowship
Tennent Institute of Ophthalmology, Glasgow, UK
Ophthalmology residency
Tennent Institute of Ophthalmology, Glasgow, UK
Medical School
King Edward Medical College, Lahore, Pakistan

Biography

Professor Amer Awan is a UK-trained Consultant Ophthalmologist and Vitreoretinal Surgeon with broad expertise in adult and pediatric retinal diseases at Shifa International Hospital, Islamabad, Pakistan. He completed his vitreoretinal fellowship at the prestigious Tennent Institute of Ophthalmology, Glasgow, and holds fellowships from the Royal College of Ophthalmologists (London), the Royal College of Surgeons (Edinburgh), and the Royal College of Physicians and Surgeons (Glasgow).

A pioneer in the adoption of 27-gauge vitrectomy in South Asia, Professor Awan has performed thousands of complex retinal and cataract surgeries. His clinical focus lies in advanced sutureless
microincision vitrectomy using both 25- and 27-gauge systems. He is a Fellow of the American Society of Retina Specialists, a Fellow of the American College of Surgeons, and an alumnus of the Harvard Medical School Surgical Leadership Program.

Professor Awan is an examiner for the Royal College of Ophthalmologists (London) and the Royal College of Physicians and Surgeons (Glasgow), and serves as a council member of several
prominent national and international ophthalmic societies. His exceptional contributions to ophthalmology have earned him multiple accolades, including the APAO Achievement Award, the
President’s Award of Excellence, and the Lateef Chaudhry Gold Medal for Vitreoretinal Services in Pakistan.

As a dedicated academic and surgical educator, he is frequently invited to deliver lectures, live surgical demonstrations, and instructional courses at leading national and international conferences. He has authored numerous peer-reviewed publications and currently serves as Principal Investigator for several multicenter clinical trials, including the Asia Pacific Ocular Trauma Study (APOTS) and the ALVOEYE Trial evaluating biosimilar Aflibercept in wet age-related macular degeneration.